MARKET

BTTX

BTTX

BETTER THERAPEUTICS INC
EXMKT
0.0001
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.610
52 WEEK LOW
0.0001
MARKET CAP
4.99K
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BTTX last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at BTTX last week (1117-1121)?
Weekly Report · 11/24 09:35
Weekly Report: what happened at BTTX last week (1110-1114)?
Weekly Report · 11/17 09:36
Weekly Report: what happened at BTTX last week (1103-1107)?
Weekly Report · 11/10 09:34
Weekly Report: what happened at BTTX last week (1027-1031)?
Weekly Report · 11/03 09:33
Weekly Report: what happened at BTTX last week (1020-1024)?
Weekly Report · 10/27 09:36
Weekly Report: what happened at BTTX last week (1013-1017)?
Weekly Report · 10/20 09:34
Weekly Report: what happened at BTTX last week (1006-1010)?
Weekly Report · 10/13 09:35
More
About BTTX
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company, which is engaged in developing a software-based novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases (CMDx). Its platform allows for the creation of multiple PDTs that are designed to treat patients with CBT, delivered digitally via an app, to address the underlying causes of CMDx. Its lead PDT product candidate, AspyreRx, is a digital behavioral therapeutic delivering CBT for the treatment of a cardiometabolic disease. AspyreRx is a prescription-only digital treatment indicated to provide cognitive behavioral therapy to patients 18 years or older with T2D. The device targets behavior to aid in the treatment of T2D. Its pipeline also includes programs for the treatment of hypertension, hyperlipidemia, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Dysfunction-Associated Steatohepatitis (MASH) and chronic kidney disease.

Webull offers Better Therapeutics Inc stock information, including EXMKT: BTTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BTTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BTTX stock methods without spending real money on the virtual paper trading platform.